BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 16997283)

  • 1. Focal adhesion kinase: a potential target in cancer therapy.
    van Nimwegen MJ; van de Water B
    Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAK expression regulation and therapeutic potential.
    Li S; Hua ZC
    Adv Cancer Res; 2008; 101():45-61. PubMed ID: 19055942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
    Schwock J; Dhani N; Hedley DW
    Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transduction by focal adhesion kinase in cancer.
    Zhao J; Guan JL
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):35-49. PubMed ID: 19169797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth.
    Shi Q; Hjelmeland AB; Keir ST; Song L; Wickman S; Jackson D; Ohmori O; Bigner DD; Friedman HS; Rich JN
    Mol Carcinog; 2007 Jun; 46(6):488-96. PubMed ID: 17219439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of focal adhesion kinase in non-small cell lung cancer.
    Carelli S; Zadra G; Vaira V; Falleni M; Bottiglieri L; Nosotti M; Di Giulio AM; Gorio A; Bosari S
    Lung Cancer; 2006 Sep; 53(3):263-71. PubMed ID: 16842883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397.
    Hamadi A; Bouali M; Dontenwill M; Stoeckel H; Takeda K; Rondé P
    J Cell Sci; 2005 Oct; 118(Pt 19):4415-25. PubMed ID: 16159962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer.
    Schultze A; Fiedler W
    Expert Opin Investig Drugs; 2010 Jun; 19(6):777-88. PubMed ID: 20465362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo.
    Watanabe N; Takaoka M; Sakurama K; Tomono Y; Hatakeyama S; Ohmori O; Motoki T; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Beer DG; Nagatsuka H; Tanaka N; Naomoto Y
    Clin Cancer Res; 2008 Jul; 14(14):4631-9. PubMed ID: 18628478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal adhesion kinase (FAK) expression and activation during lens development.
    Kokkinos MI; Brown HJ; de Iongh RU
    Mol Vis; 2007 Mar; 13():418-30. PubMed ID: 17417603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of focal adhesion kinase correlates with cellular proliferation and apoptosis during 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis.
    Xia J; Lv N; Hong Y; Li C; Tao X; Chen X; Cheng B
    J Oral Pathol Med; 2009 Jul; 38(6):524-9. PubMed ID: 19141060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin inhibited migration and invasion of human ovarian cancer A2780 cells through focal adhesion kinase.
    Hu XW; Meng D; Fang J
    Carcinogenesis; 2008 Dec; 29(12):2369-76. PubMed ID: 18974065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
    Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
    Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
    Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
    Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
    Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The signaling and biological implications of FAK overexpression in cancer.
    Siesser PM; Hanks SK
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3233-7. PubMed ID: 16740741
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549.
    Liu G; Meng X; Jin Y; Bai J; Zhao Y; Cui X; Chen F; Fu S
    Cell Biol Int; 2008 Jun; 32(6):663-70. PubMed ID: 18343694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin plays a key regulatory role via a p53/FAK-dependent signaling in melanoma cell adhesion and migration.
    Chalkiadaki G; Nikitovic D; Berdiaki A; Katonis P; Karamanos NK; Tzanakakis GN
    IUBMB Life; 2011 Feb; 63(2):109-19. PubMed ID: 21360640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells.
    Garces CA; Kurenova EV; Golubovskaya VM; Cance WG
    Cancer Res; 2006 Feb; 66(3):1446-54. PubMed ID: 16452200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
    Peng L; Ran YL; Hu H; Yu L; Liu Q; Zhou Z; Sun YM; Sun LC; Pan J; Sun LX; Zhao P; Yang ZH
    Carcinogenesis; 2009 Oct; 30(10):1660-9. PubMed ID: 19625348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.